Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.76 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.76 |
| ▸ | POLB | P06746 | 4/20 | 0.76 |
| ▸ | MEN1 | O00255 | 3/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.76 |
| ▸ | BLM | P54132 | 1/20 | 0.76 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.76 |
| ▸ | HTT | P42858 | 12/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.59 |
| ▸ | MAPT | P10636 | 8/20 | 0.59 |
| ▸ | NPC1 | O15118 | 6/20 | 0.59 |
| ▸ | XBP1 | P17861 | 2/20 | 0.59 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.59 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.59 |
| ▸ | MITF | O75030 | 5/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10642561 | 0.86 | RAB9A (1.00) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL18980164 | 0.82 | RAB9A (0.76) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL19000702 | 0.82 | RAB9A (0.76) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL19000701 | 0.82 | NPSR1 (0.76) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL19000698 | 0.82 | NPSR1 (0.76) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL4060991 | 0.80 | NPSR1 (0.72) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL1691901 | 0.80 | HTT (0.71) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL18980016 | 0.79 | RAB9A (0.70) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL19000729 | 0.79 | NPBWR1 (0.72) | RAB9ANPSR1SMN1; SMN2POLBMEN1 | |
| SCHEMBL19000725 | 0.79 | RAB9A (0.70) | RAB9ANPSR1SMN1; SMN2POLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170173008-A1 | ANTIMICROBIAL AGENTS AND SCREENING METHODS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-06-22 | — | — | US | disclosed |
| US-20170173008-A1 | ANTIMICROBIAL AGENTS AND SCREENING METHODS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170173008-A1 | ANTIMICROBIAL AGENTS AND SCREENING METHODS | BAK1, DCLRE1B, BLVRB | RAB9A 3085/4885NPSR1 4642/4885SMN1; SMN2 4088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.